Literature DB >> 6625787

Corynebacterium xerosis endocarditis.

R Eliakim, P Silkoff, G Lugassy, J Michel.   

Abstract

Bacterial endocarditis due to Corynebacterium xerosis developed in a previously healthy person. Diphtheroid infection is a rare cause of endocarditis and, when present, it usually affects immunocompromised hosts or prosthetic valves. There are few reports of diphtheroid endocarditis on intact valves, and, to our knowledge, this is the first case in which the offending organism was identified as C xerosis. We call attention to the virulence of C xerosis in a person with no previous valvular disease.

Entities:  

Mesh:

Year:  1983        PMID: 6625787

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  6 in total

Review 1.  Coryneform bacteria in infectious diseases: clinical and laboratory aspects.

Authors:  M B Coyle; B A Lipsky
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

2.  Corynebacterium CDC group A-4 native valve endocarditis.

Authors:  A Lifshitz; N Arber; E Pras; Z Samra; J Pinkhas; Y Sidi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-12       Impact factor: 3.267

3.  Corynebacterium xerosis as a cause of vertebral osteomyelitis.

Authors:  G Krish; W Beaver; F Sarubbi; A Verghese
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

4.  Native valve endocarditis caused by an organism resembling Corynebacterium striatum.

Authors:  S M Markowitz; P E Coudron
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

5.  Antimicrobial susceptibilities of a Corynebacterium CDC group I1 strain isolated from a patient with endocarditis.

Authors:  G J Malanoski; R Parker; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

6.  Corynebacterium endocarditis species-specific risk factors and outcomes.

Authors:  Jaime Belmares; Stephanie Detterline; Janet B Pak; Jorge P Parada
Journal:  BMC Infect Dis       Date:  2007-02-06       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.